Anxiety in Relation to Nausea and Vomiting in Pregnancy

Anxiety Clinical Trial

Official title: Assessment of Anxiety Disorder in Relation to PUQE Score of Nausea and Vomiting in First Trimester Pregnancy

Status Completed

Clinical Trial Summary

The goal of this observational study is to learn more about the relation between anxiety (assessed by GAD-7 questionnaire) and the nausea and vomiting in pregnancy (objectively measured by PUQE score). Participants will answer 2 questionnaires: (GAD-7) for anxiety; and (PUQE score) for nausea and vomiting.

Clinical Trial Description

Study Procedures: - Protocol approval will be sought from the ethical committee of the department of Obstetrics & Gynecology, Faculty of Medicine, Ain Shams University. - Recruitment of pregnant women complaining of nausea and vomiting in pregnancy (NVP) in first trimester will be done from the outpatient clinic and antenatal ward in Ain Shams University Maternity Hospital. - An informed written consent will be taken from all participants before enrollment in the study. - History taking, examination, and investigations (CBC, ultrasound, acetone in urine, serum sodium, potassium, alanine transaminase (ALT), aspartate transaminase (AST), serum creatinine) will be done to identify eligible patients according to the inclusion and exclusion criteria. - PUQE score will be calculated for each patient. Patients will be classified into 3 groups (mild, moderate, severe) accordingly. - GAD-7 questionnaire will be calculated for each patient. Degree of anxiety will be classified into 4 groups (minimal, mild, moderate, severe) accordingly. - Data will be recorded in a case report form. - Statistical analysis will be done accordingly. ;

Related Conditions & MeSH terms

• Anxiety
• Anxiety Disorders
• Nausea
• Nausea Gravidarum
• Vomiting

• NCT number: NCT06059794
• Study type: Observational
• Source: Ain Shams Maternity Hospital
• Status: Completed
• Start date: January 1, 2023
• Completion date: March 19, 2024